Tag: Paul R. Gugliuzza

New NEJM article examines how courts are using FDA-required labeling to decide patent infringement claims.

Professor Paul Gugliuzza, Assistant Professor Susan Yorke, and AI Innovation Fellow Kevin Frazier join Texas Law.